How to takeCalocurb

Even small reductions in meal size — cutting 100 calories from each — can create a daily deficit of 300–600 calories, equating to 0.7–1.3 lbs of loss per week.

Calocurb's Amarasate^® activates bitter taste receptors (TAS2Rs) in the gut, triggering GLP-1, CCK, and PYY release — the "I'm full" hormone cascade. In clinical studies, this doubled the normal post-meal GLP-1 rise and reduced subsequent food intake by nearly 20%.

When you stop a GLP-1 medication, your body faces a double challenge: the drug is gone, and your natural GLP-1 production has been suppressed by the medication (typically within 14 weeks of starting it). This is why most people regain weight after stopping — it's not a willpower issue.

Starting Calocurb during the final week of your last injection gives your natural satiety signals a chance to recover. Amarasate^® stimulates the same GLP-1 pathway as the medication, helping to bridge the transition. It also activates the release of two other “stop eating” hormones, CCK and PYY.

Begin Calocurb during the same week as your last injection. If you're on oral GLP-1 medication, start during the final week of your usual dose.

Because your gut has already been sensitized by the GLP-1 RA, most people tolerate Calocurb with fewer initial GI effects than someone starting from scratch.

Some people notice a mild laxative effect when first starting — this usually resolves within 24–48 hours. If this occurs, reduce to 1 capsule per dose and increase again after 2–3 days.

Most users report feeling fuller more quickly and experiencing quieter "food noise" within the first week. Results are best when taken on a genuinely empty stomach.

As estrogen levels decline, the brain's satiety signalling weakens — you feel less satisfied from the same meals, and cravings (especially for sweets) increase. Studies show women gain an average of 3.3 lbs per year during the menopause transition, often shifting from a pear to an apple body shape.

GLP-1 is one of the key hormones that signals fullness after eating. Because estrogen supports GLP-1 sensitivity, its decline means the "I'm full" message gets quieter. Calocurb works directly on gut GLP-1 production, helping to restore that signal.

• Aim for roughly 200 fewer calories per day — small portion reductions at each meal add up without feeling like deprivation
• Increase protein proportion of your diet to support muscle maintenance and satiety
• Moderate aerobic exercise plus strength training helps counteract muscle loss and slowing metabolism
• Calocurb can be used alongside HRT — speak with your healthcare provider about combining approaches

GLP-1 medications suppress your body's own natural GLP-1 production — typically within 14 weeks. Calocurb stimulates your gut cells to produce GLP-1 via a different mechanism (bitter taste receptor activation), helping to maintain natural production during treatment.

Some practitioners report that patients using Calocurb alongside GLP-1 RAs are able to achieve comparable results at lower medication doses — potentially reducing side effects.

Most people tolerate Calocurb well when already on a GLP-1 RA. Begin in week 2 — not week 1 — to let your body adjust to the medication first.

If you experience increased GI symptoms, reduce to 1 capsule per dose and increase gradually. Add an evening capsule if late-night eating is a challenge.

Food noise is the term used to describe persistent and intrusive food-related thoughts, even with no food cues present (such as sights or smells). It's very common — nearly 60% of people in one survey reported it, and it was even more common in those living with overweight or obesity. It's more than a nuisance: it makes it harder to stick to a nutrition plan or make healthy food choices.

GLP-1 medications like Ozempic/Wegovy and Zepbound/Mounjaro work partly by quieting this food noise signal. Calocurb's Amarasate^® increases your body's own natural GLP-1 production — by six times baseline in one study — helping to turn down the volume on food noise without a prescription.

• TRE eating window 12pm–8pm: take Calocurb at 8am (during fasting window)
• TRE eating window 9am–5pm: take Calocurb at 8pm (after eating window closes)
• Increase frequency to every 4 hours during fasting if hunger is significant

Intermittent fasting reduces fullness hormones including GLP-1 and leptin, which is why people often feel hungry during fasting periods. In clinical trials, Calocurb reduced both overall hunger and cravings during 24-hour water-only fasts — reducing hunger by 30% in women and 20% in men.

PCOS affects 10–13% of women and is closely linked to overweight/obesity — 50–80% of women with PCOS live with these conditions. Weight management helps prevent worsening symptoms and associated conditions like diabetes and heart disease, and supports mental health.

Calocurb can be used alone, alongside GLP-1 RA medications, or as a transition tool when stopping them. It addresses the gut hormone disruption common in PCOS, where natural GLP-1 signalling is often impaired.

In the luteal phase (the ~2 weeks before your period), lower estrogen combined with rising progesterone significantly increases appetite. Studies show women eat over 200 calories more per day before and during their period — mostly sweet, high-fat foods.

For the 85% of women who experience PMS, cravings can be even more intense — potentially 500+ extra calories per day during peak craving time. Calocurb helps dampen this signal by boosting GLP-1, which reduces both appetite and "food noise".

Short-term exercise briefly suppresses ghrelin (the hunger hormone). But with sustained long-term training, the body adapts: ghrelin production increases as the body tries to compensate for the energy expended. This is why people who train regularly often find they eat more than they intend to — and undo the calorie deficit they've worked to create.

Calocurb addresses the other side of the equation by boosting GLP-1 — the satiety signal — helping you feel genuinely satisfied from appropriately sized meals after training.